David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$453M |
| 2 |
Oracle
ORCL
|
+$431M |
| 3 |
Apple
AAPL
|
+$376M |
| 4 |
SLB Ltd
SLB
|
+$353M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$746M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
NVIDIA
NVDA
|
+$348M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$307M |
| 5 |
AT&T
T
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.42% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 11.33% |
| 4 | Financials | 7.58% |
| 5 | Communication Services | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVAX
676
DELISTED
Dynavax Technologies
DVAX
| $21M | 0.03% |
2,294,520
+192,770
| +9% | +$2.13M |
|
|
ATSG
677
DELISTED
Air Transport Services Group
ATSG
| $21M | 0.03% |
919,772
+118,056
| +15% | +$2.32M |
|
|
SYNH
678
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $20.9M | 0.03% |
531,991
+120,829
| +29% | +$5.61M |
|
679
Royal Bank of Canada
RY
$284B
| $20.9M | 0.03% |
304,588
-74,899
| -20% | -$5.47M |
|
680
Eastman Chemical
EMN
$8.31B
| $20.8M | 0.03% |
284,368
+281,063
| +8,504% | +$22.4M |
|
681
GSK
GSK
$104B
| $20.5M | 0.03% |
+429,680
| New | +$21.2M |
|
682
COPT Defense Properties
CDP
$4.25B
| $20.5M | 0.03% |
+975,339
| New | +$24.8M |
|
|
RTEC
683
DELISTED
Rudolph Technologies Inc
RTEC
| $20.5M | 0.03% |
999,906
-30,566
| -3% | -$620K |
|
684
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
| $20.4M | 0.03% |
432,163
-591,090
| -58% | -$28.6M |
|
|
FSAC
685
DELISTED
Federal Street Acquisition Corp. Common Stock
FSAC
| $20.4M | 0.03% |
+1,990,000
| New | +$20M |
|
686
First American
FAF
$7.38B
| $20.3M | 0.03% |
455,420
-169,870
| -27% | -$7.88M |
|
687
CALL
RH
RH
$2.71B
| $20.2M | 0.03% |
168,800
+8,500
| +5% | +$1.02M |
|
688
CALL
Elevance Health
ELV
$87.3B
| $20.2M | 0.03% |
77,000
+9,900
| +15% | +$2.72M |
|
|
X
689
CALL
DELISTED
US Steel
X
| $20.1M | 0.03% |
1,102,700
+282,800
| +34% | +$7.08M |
|
|
ABMD
690
CALL
DELISTED
Abiomed Inc
ABMD
| $20.1M | 0.03% |
61,800
+17,700
| +40% | +$6.15M |
|
691
BioMarin Pharmaceuticals
BMRN
$12.6B
| $20.1M | 0.03% |
235,769
+137,558
| +140% | +$13.1M |
|
692
General Mills
GIS
$21.9B
| $20.1M | 0.03% |
515,510
+365,577
| +244% | +$15.4M |
|
693
CALL
Coca-Cola
KO
$396B
| $20.1M | 0.03% |
423,800
-73,200
| -15% | -$3.5M |
|
694
Jazz Pharmaceuticals
JAZZ
$16.5B
| $20M | 0.03% |
161,715
+63,100
| +64% | +$9.36M |
|
695
SM Energy
SM
$8.67B
| $20M | 0.03% |
1,294,861
+53,454
| +4% | +$1.24M |
|
696
CALL
Mercado Libre
MELI
$98.8B
| $20M | 0.03% |
68,400
| – | – |
|
697
PUT
FedEx
FDX
$79.1B
| $20M | 0.03% |
124,100
-115,200
| -48% | -$24.4M |
|
|
NEWR
698
DELISTED
New Relic, Inc.
NEWR
| $20M | 0.03% |
247,063
-27,569
| -10% | -$2.32M |
|
|
TMHC
699
DELISTED
Taylor Morrison
TMHC
| $19.9M | 0.03% |
1,250,665
+42,959
| +4% | +$701K |
|
700
CALL
CVS Health
CVS
$120B
| $19.9M | 0.03% |
303,450
+44,950
| +17% | +$3.36M |
|
Similar funds
David Shaw's Q4 2018 Portfolio in Review
As of Q4 2018, David Shaw held 4,217 positions worth $72.6B, down 13% from $83.2B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
David Shaw deployed $3.99B of net new capital in Q4 2018, opening 541 new positions and adding to 1,544 existing holdings. Its largest new stake was Alibaba: 3,066,336 shares worth $420M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $746M trimmed.
- David Shaw's largest Q4 2018 buy was Alibaba: 3,066,336 shares worth $420M.
- David Shaw added most to Oracle in Q4 2018, an estimated $431M increase.
- David Shaw's biggest Q4 2018 reduction was Amazon, cutting an estimated $746M.
- David Shaw fully exited Aetna Inc in Q4 2018, selling an estimated $378M.
- David Shaw's ten largest holdings make up 8.9% of its $72.6B portfolio in Q4 2018.
- David Shaw opened 541 new positions and closed 497 in Q4 2018.
- David Shaw's portfolio value fell 13% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.